A phase II multicenter study of stereotactic radiotherapy (SRT) for oligoprogression in metastatic renal cell cancer (mRCC) patients receiving tyrosine kinase inhibitor (TKI) therapy. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Cheung, Patrick
  • Patel, Samir
  • North, Scott A
  • Sahgal, Arjun
  • Chu, William
  • Soliman, Hany
  • Ahmad, Belal
  • Winquist, Eric
  • Patenaude, Francois
  • Niazi, Tamim
  • Heng, Daniel Yick Chin
  • Lim, Gerald
  • Dubey, Arbind
  • Czaykowski, Piotr
  • Wong, Rebecca
  • Swaminath, Anand
  • Morgan, Scott Carlyle
  • White, Justin
  • Keshavarzi, Sareh
  • Bjarnason, Georg A

publication date

  • May 20, 2020